Followers | 18 |
Posts | 3416 |
Boards Moderated | 1 |
Alias Born | 11/28/2015 |
Thursday, March 31, 2016 1:52:25 PM
Cash sales were $94.1 million for fiscal year 2015 compared to $81.9 million in fiscal year 2014, an increase of $12.2 million or 15%.
Revenue was $87.2 million for 2015 compared to $96.5 million for the previous year.
Revenue from attendance increased $3.1 million, or 5%, in 2015 compared to the previous year.
Non-U.S. revenue was $28.9 million for 2015 compared to $26.1 million in the previous year, an increase of $2.8 million or 11%.
Net cash provided by operating activities was $2.8 million in 2015 compared to net cash used in operating activities of $(1.7) million in the previous year, an increase in cash of $4.5 million.
Total operating costs were $90.3 million for 2015 compared to $90.9 million for the previous year, a decrease of $0.6 million or 1%.
Net loss was $2.7 million, or $0.12 per basic and diluted common share, for 2015, compared to net income of $7.4 million, or $0.45 per basic common share and $0.42 per diluted common share, for the previous year.
Recent LEAI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:25:54 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 07:36:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 09:20:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:31:46 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:05:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 12:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 08:30:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/07/2023 05:22:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM